Tucidinostat restores CCR4 expression in adult T-cell leukemia/lymphoma

被引：1
|
作者：
Kawata, Takahito [2 ]
Shimizu, Takuya [2 ]
Shindo, Takero [2 ]
Fujiwara, Kensuke [1 ]
Morimoto, Suguru [1 ]
Watanabe, Mitsumasa [1 ]
机构：
[1] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Hematol, Amagasaki, Japan
[2] Kyoto Univ, Dept Hematol Oncol, Grad Sch Med, Kyoto, Japan
来源：
HAEMATOLOGICA | 2024年 / 109卷 / 03期
关键词：
LEUKEMIA;
D O I：
10.3324/haematol.2023.283266
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1007 / 1009
页数：3
相关论文
共 50 条
  • [31] Involvement of fra-2 and JunD in CCR4 expression and cell proliferation in adult T cell leukemia
    Nakayama, Takashi
    Hieshima, Kunio
    Jin, Zhe
    Nagakubo, Daisuke
    Shirakawa, Aiko-Konno
    Yamada, Yasuaki
    Fujii, Masahiro
    Yoshie, Osamu
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (04) : 642 - 643
  • [32] Development of a novel Indium-111 radiolabeled mogamulizumab targeting CCR4 for imaging adult T-cell leukemia/lymphoma in vivo
    Shimizu, Yoichi
    Koyasu, Sho
    Suzukida, Mari
    Izumi, Kiyotaka
    Kidera, Eitaro
    Shindo, Takero
    Saga, Tsuneo
    Ono, Masahiro
    Takaori-Kondo, Akifumi
    Nakamoto, Yuji
    ANNALS OF NUCLEAR MEDICINE, 2022, 36 (03) : 319 - 326
  • [33] Development of a novel Indium-111 radiolabeled mogamulizumab targeting CCR4 for imaging adult T-cell leukemia/lymphoma in vivo
    Yoichi Shimizu
    Sho Koyasu
    Mari Suzukida
    Kiyotaka Izumi
    Eitaro Kidera
    Takero Shindo
    Tsuneo Saga
    Masahiro Ono
    Akifumi Takaori-Kondo
    Yuji Nakamoto
    Annals of Nuclear Medicine, 2022, 36 : 319 - 326
  • [34] CCR4 in cutaneous T-cell lymphoma: Therapeutic targeting of a pathogenic driver
    Nicolay, Jan P.
    Albrecht, Jana D.
    Alberti-Violetti, Silvia
    Berti, Emilio
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 (07) : 1660 - 1671
  • [35] Small-Molecule CCR4 Antagonists in Cutaneous T-cell Lymphoma
    Enriquez, Jose S.
    Wang, Xiaohong
    Velatooru, Loka Reddy
    Han, Wei
    Bijani, Pedram
    Ni, Xiao
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (10): : 2756 - 2765
  • [36] Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma
    Beygi, Sara
    Duran, George E.
    Fernandez-Pol, Sebastian
    Rook, Alain H.
    Kim, Youn H.
    Khodadoust, Michael S.
    BLOOD, 2022, 139 (26) : 3732 - 3736
  • [37] Upregulation of the chemokine receptor CCR4 in cutaneous T-cell lymphoma and nodal T-cell lymphoma: Implications for targeted therapy
    Jones, D
    Patel, K
    Herling, M
    Aguilar, RJ
    Ueda, R
    Inagaki, H
    Fayad, L
    Duvic, M
    BLOOD, 2004, 104 (11) : 724A - 724A
  • [38] CCR4 Expression in Hodgkin Lymphoma
    Visser, Lydia
    van West, Myrna
    Rutgers, Bea
    Poppema, Sibrand
    Van Den Berg, Anke
    BLOOD, 2011, 118 (21) : 1128 - 1128
  • [39] HDAC inhibitors decrease mogamulizumab efficacy with downregulation of CCR4 in T-cell lymphoma
    Kitadate, Akihiro
    Ikeda, Sho
    Abe, Fumito
    Teshima, Kazuaki
    Takahashi, Naoto
    Matsue, Kosei
    Tagawa, Hiroyuki
    CANCER SCIENCE, 2018, 109 : 506 - 506
  • [40] Adult T-Cell Leukemia/Lymphoma
    Qayyum, Sohail
    Choi, John K.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (02) : 282 - 286
12345